Vascularization is a major challenge in the field of tissue engineering and regenerative medicine. Mechanical factors have been demonstrated to play a fundamental role in vasculogenesis and angiogenesis and can affect the architecture of the generated vascular network. Through the regulation of mechanical factors in engineered tissues, various mechanical strategies can be used to optimize the preformed vascular network and promote its rapid integration with host vessels. Optimization of the mechanical properties of scaffolds, including controlling scaffold stiffness, increasing surface roughness and anisotropic structure, and designing interconnected, hierarchical pore structures, is beneficial for the in vitro formation of vascular networks and the ingrowth of host blood vessels. The incorporation of hollow channels into scaffolds promotes the formation of patterned vascular networks. Dynamic stretching and perfusion can facilitate the formation and maturation of preformed vascular networks in vitro. Several indirect mechanical strategies provide sustained mechanical stimulation to engineered tissues in vivo, which further promotes the vascularization of implants within the body. Additionally, stiffness gradients, anisotropic substrates and hollow channels in scaffolds, as well as external cyclic stretch, boundary constraints and dynamic flow culture, can effectively regulate the alignment of vascular networks, thereby promoting better integration of prevascularized engineered tissues with host blood vessels. This review summarizes the influence and contribution of both scaffold-based and external stimulus-based mechanical strategies for vascularization in tissue engineering and elucidates the underlying mechanisms involved.
- Article type
- Year
- Co-author
Open Access
Review
Issue
Open Access
Review
Issue
The stagnation of diabetic wound healing is a formidable global health challenge that is fundamentally driven by the dysregulation of macrophage plasticity. In the diabetic microenvironment, macrophages remain in a persistent pro-inflammatory (M1) state and fail to transition to the reparative (M2) phenotype essential for tissue regeneration. This review systematically elucidates the molecular pathology of this ‘conversion failure’ from a superficial to an in-depth level and provides a detailed explanation of the mechanisms underlying aberrant macrophage polarization in diabetic wounds, ranging from microenvironmental abnormalities to dysregulated signalling pathways. These perturbations create a vicious cycle of chronic inflammation, impaired angiogenesis, and pathological fibrosis. To address these challenges, we comprehensively outline current therapeutic strategies, including approaches that range from the precision molecular reprogramming of intracellular signalling hubs and gene networks to the engineering of microenvironment-responsive biomaterials capable of neutralizing oxidative stress and responding to pathological cues. Furthermore, we highlight the integration of exogenous bioactivity through stem cell– and exosome-based therapies aimed at replenishing the regenerative niche. Additionally, we critically assess translational bottlenecks, suggesting a paradigm shift from the binary M1/M2 model towards targeting intermediate phenotypes identified by single-cell multiomics. By integrating mechanistic insights with advanced immunomodulatory engineering, this review provides a theoretical framework for developing next-generation precision therapies to reverse the chronic nature of diabetic wounds.
Open Access
Research Article
Issue
Patients with extensive and deep skin defects treated with dermal scaffolds usually emphasize the importance of rapid angiogenesis, while overlook the crucial role of skin nerves in regenerative repair. Insufficient early nerve regeneration not only impedes skin reinnervation and angiogenesis, but also damages the synergistic effects among them, eventually hinders healing quality. Nerve growth factor (NGF) has shown potent potential in peripheral nerve regeneration and promotion of angiogenesis. Angiogenin (ANG) is an independent angiogenic factor, supplying microenvironment needed for neurogenesis. This study presents a dermal scaffold with dual gene activity, fabricated by incorporating nanoparticles (NPs) composed of polyethylenimine (PEI)-chimeric plasmids encoding both NGF and ANG (PEI-plasmid NGF/ANG dermal scaffold (NADS)). Specifically, NADS achieves sustained and in situ release of these two factors, and encourages the repair cells to fulfill their regenerative roles. In vivo experiments confirm the efficacy of NADS in promoting fully functional innervated skin regeneration, inducing the fastest healing rates and rapidly facilitating the formation of a mature vascular network, thus resulting in high-quality wound healing. This approach offers an effective and comprehensive strategy for clinical application.
京公网安备11010802044758号